Naoki Horikawa
Overview
Explore the profile of Naoki Horikawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka Y, Horikawa N, Nishimura T, Kiyokawa H, Fukuhara K
Cureus
. 2025 Mar;
17(2):e78747.
PMID: 40070637
Endometriosis, while prevalent, can manifest in extra-pelvic locations with varying degrees of rarity, but reports of multiple extra-pelvic sites within a patient are extremely rare. We report a unique case...
2.
Hamada K, Yamanoi K, Hayashi N, Kotani Y, Matsumoto H, Horikawa N, et al.
Int J Clin Oncol
. 2025 Jan;
30(3):584-592.
PMID: 39815053
Background: In 2018, the International Federation of Gynecology and Obstetrics (FIGO) revised its cervical cancer staging system to enhance clinical relevance, notably by categorizing lymph node metastases (LNM) as an...
3.
Sakurai A, Yamaguchi K, Ishida K, Horikawa N, Kawai E, Kotani Y, et al.
Int J Clin Oncol
. 2025 Jan;
30(3):570-583.
PMID: 39779654
Introduction: Uterine carcinosarcoma (UCS) and uterine sarcomas (US) are rare but aggressive cancer with poor prognoses. The prognostic value of systemic inflammatory response (SIR) indicators, including the neutrophil-to-lymphocyte ratio (NLR),...
4.
Ota Y, Ota K, Takahashi T, Horikawa N, Kuroda R, Okamoto H, et al.
Front Med (Lausanne)
. 2024 Oct;
11:1457611.
PMID: 39391043
Objective: Adenomyosis-related infertility is increasingly being diagnosed, and surgical intervention has been suggested to improve fertility. Elastography, a noninvasive ultrasound technique, is promising for diagnosing and guiding the resection of...
5.
Umemiya M, Horikawa N, Kanai A, Saeki A, Ida K, Makio S, et al.
Case Rep Oncol
. 2023 Nov;
16(1):634-639.
PMID: 37933313
Lynch syndrome is an autosomal dominant inherited disorder caused by a germline pathogenic variant in DNA mismatch repair genes, resulting in multi-organ cancer. Annual transvaginal ultrasonography and endometrial biopsy are...
6.
Iida Y, Fukushima W, Nakamura Y, Miyanaga S, Horikawa N, Yabushita K
Gan To Kagaku Ryoho
. 2022 Sep;
49(9):957-961.
PMID: 36156014
Purpose: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer 2018 indicated that operation is the standard treatment for breast cancer in elderly patients. This study aimed to...
7.
Umemiya M, Inayama Y, Nakatani E, Ito K, Tsuji M, Yoshida T, et al.
Drugs R D
. 2022 Aug;
22(4):263-269.
PMID: 35987938
Background And Objectives: Irinotecan sometimes causes lethal septic shock but the risk factors remain unclear. This retrospective case-control study explored the potential risk factors for septic shock following irinotecan treatment....
8.
Horikawa N, Horie A, Kawahara S, Sunada M, Chigusa Y, Yamaguchi K, et al.
JSLS
. 2022 Apr;
26(1).
PMID: 35444399
Background: Radiological evaluation of para-aortic lymph node metastasis in patients with locally advanced cervical cancer (LACC) possess the risk of missing microscopic metastasis. We commenced laparoscopic para-aortic lymphadenectomy (Lap-PAN) on...
9.
Gou R, Horikawa N, Kosaka K
BMJ Case Rep
. 2022 Apr;
15(4).
PMID: 35444023
Over the past decade, the treatment of ovarian cancer has been revolutionised by poly(ADP-ribose polymerase (PARP)) inhibitors. Based on the results from clinical trials, olaparib, a PARP inhibitor, is indicated...
10.
Fujitsuka S, Horikawa N, Yoshida T, Yu S, Kuroda R, Tsuji M, et al.
Case Rep Oncol
. 2022 Apr;
15(1):156-162.
PMID: 35431873
Chemotherapy-induced severe hyponatremia is a life-threatening condition. Platinum-based agents play a key role in ovarian cancer treatment but are more likely to cause hyponatremia than other anticancer agents. The optimal...